单位:[1]Peking Univ, Dept Infect Dis, Hosp 1, Beijing 100034, Peoples R China[2]Capital Med Univ, Beijing You An Hosp, Artificial Liver Ctr, Beijing 100069, Peoples R China[3]Capital Med Univ, Beijing You An Hosp, Ctr Hepatol & Gastroenterol, Beijing, Peoples R China[4]302 Mil Hosp China, Liver Tumor Diag Treatment & Res Ctr, Beijing, Peoples R China[5]Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[6]Peking Univ, Peoples Hosp, Inst Hepatol, Beijing, Peoples R China[7]Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China[8]Peking Univ, Dept Pathogen Biol, Hlth Sci Ctr, Beijing, Peoples R China
The Chinese Society of Hepatology developed the current guidelines for the Management of Ascites and Its Related Complications in Cirrhosis based on the published evidences and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of cirrhotic ascites emphasizing a step-wise approach with the first-, second-, and third-line therapy. For refractory ascites, vasoconstrictors and albumin are recommended for splanchnic vasodilation and selective vasopressin (V2) receptor antagonists for moderate-to-severe hyponatremia. For spontaneous bacterial peritonitis, empirical anti-infection treatment was recommended based on the local microbiological examination of community- or hospital-acquired infections. For hepatorenal syndrome, the administration of vasopressor terlipressin and albumin is recommended.
第一作者单位:[1]Peking Univ, Dept Infect Dis, Hosp 1, Beijing 100034, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Xu Xiaoyuan,Duan Zhongping,Ding Huiguo,et al.Chinese guidelines on the management of ascites and its related complications in cirrhosis[J].HEPATOLOGY INTERNATIONAL.2019,13(1):1-21.doi:10.1007/s12072-018-09923-2.
APA:
Xu, Xiaoyuan,Duan, Zhongping,Ding, Huiguo,Li, Wengang,Jia, Jidong...&Zhuang, Hui.(2019).Chinese guidelines on the management of ascites and its related complications in cirrhosis.HEPATOLOGY INTERNATIONAL,13,(1)
MLA:
Xu, Xiaoyuan,et al."Chinese guidelines on the management of ascites and its related complications in cirrhosis".HEPATOLOGY INTERNATIONAL 13..1(2019):1-21